Dissecting NF-kB pathway in HPV-associated head and neck cancer
Dissecting NF-kB pathway in HPV-associated head and neck cancer
批准号:
10660309
负责人:
Natalia Issaeva
金额:
$48.87万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-01 至 2027-12-31
关键词:
Automobile DrivingBioinformaticsBiological MarkersCD4 Positive T LymphocytesCancer EtiologyCell ProliferationCellsCharacteristicsClassificationClinical TrialsCoupledCytoprotectionDataDefectDeglutitionDiseaseDown-RegulationEngineeringEpidemicEpisomeEtiologyFunctional disorderGene ExpressionGenesGoalsHead and Neck Squamous Cell CarcinomaHead and neck structureHuman Papilloma Virus-Related Malignant NeoplasmHuman PapillomavirusHuman papillomavirus 16In complete remissionIncidenceInfiltrationMaintenanceMediatingModelingMorbidity - disease rateMutationNF-kappa BOncologyOxidative StressPapillomavirus Transforming Protein E6Pathway AnalysisPathway interactionsPatientsPatternPrognosisPrognostic MarkerQuality of lifeRadiationRadiation ToleranceRadiation therapyRecurrenceRecurrent tumorReportingRiskRoleSignal TransductionSpeechSurvivorsTNF receptor-associated factor 3TestingTherapeuticTobaccoTreatment FailureViral GenesWorkanti-tumor immune responsebiological adaptation to stresscarcinogenesiscervical and uterine cancerchemotherapycohorteffective therapyhigh riskhuman papilloma virus oncogeneimmune cell infiltrateimprovedmetaplastic cell transformationnovel therapeuticsoral HPV-positive head and neck cancerspersonalized cancer carepromoterprotective pathwayresponseside effectsurvival predictiontreatment responsetumortumor microenvironmenttumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project summary
The incidence of HPV-associated (HPV+) head and neck squamous cell carcinoma (HNSCC) has
dramatically increased over the last few decades and continues to rise. Despite the magnitude of this epidemic,
mechanisms of HPV-driven carcinogenesis in HPV+ HNSCC have not been thoroughly investigated. Compared
to patients with tobacco-associated HNSCC, those with HPV+ HNSCC have increased overall survival and
higher response to treatment, which usually consists of chemo- and radiation therapy; however, survivors
frequently suffer from treatment’s toxic side effects, such as swallowing and speech dysfunction. In addition,
approximately 25% of HPV+ HNSCC patients develop recurrent or metastatic disease, for which there are limited
treatment options. A pressing goal in head and neck oncology is to decrease the morbidity of therapy for HPV+
HNSCC through treatment de-escalation. However, biomarkers that identify HPV+ patients with good prognosis,
who may be appropriate for de-escalation therapy, are lacking. Using three independent cohorts, we found that
constitutively active NF-κB (usually arising from genetic defects in NF-κB regulators, including TRAF3 and CYLD)
correlates with survival and should be explored as a prognostic biomarker in HPV+ HNSCC. Our preliminary
data suggest that survival benefits of patients, whose tumors harbor overactive NF-κB, are attributed to better
tumor response to therapy and that both, inherent NF-κB-driven tumor characteristics (e.g. downregulated
expression of oxidative stress response, NRF2 target genes), as well as a distinct tumor microenvironment (e.g.
elevated number of tumor infiltrating CD4+ T cells), may contribute to increased sensitivity of NF-κB active
tumors to radiation. We previously reported that mutations in TRAF3 and CYLD were associated with a lack of
HPV integration, leading us to hypothesize that NF-κB activation may enable cells to maintain HPV episomes.
Since the canonical HPV carcinogenesis model depends on HPV integration, we also hypothesize that activation
of NF-κB may be critical for an alternative mechanism of HPV carcinogenesis driven by HPV episomal
maintenance. To explore our hypothesis, in Specific Aim 1, we will investigate the impact of NF-κB signaling on
HPV gene expression and episomal maintenance. In Specific Aim 2, we will explore the significance of NF-κB
pathway on cellular proliferation, survival, and cellular transformation in response to HPV. Finally, Specific Aim
3 will explore mechanisms of NF-κB mediated radiation sensitivity in HPV+ HNSCC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Observational study to validate circulating HPVDNA and prognostic genomic biomarkers for diagnosis and treatment of HPV-associated OPSCC
-
批准号:10458612
-
项目类别:
-
资助金额:$74.13万
-
财政年份:2020
-
负责人:Natalia Issaeva
-
依托单位:
Observational study to validate circulating HPVDNA and prognostic genomic biomarkers for diagnosis and treatment of HPV-associated OPSCC
-
批准号:10197101
-
项目类别:
-
资助金额:$76.15万
-
财政年份:2020
-
负责人:Natalia Issaeva
-
依托单位:
Observational study to validate circulating HPVDNA and prognostic genomic biomarkers for diagnosis and treatment of HPV-associated OPSCC
-
批准号:10615775
-
项目类别:
-
资助金额:$73.56万
-
财政年份:2020
-
负责人:Natalia Issaeva
-
依托单位:
海外基金